Stress hormone-related psychopathology: Pathophysiological and treatment implications

World Journal of Biological Psychiatry

Volumn 2, Issue 3, 2001, Pages 115-143

  Wolkowitz, Owen M ^a   Epel, Elissa S ^a   Reus, Victor I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

allostasis; antiglucocorticoid; BDNF; cortisol; Cushing's Syndrome; dehydroepiandrosterone (DHEA); depression; hippocampus; memory; Metabolic Syndrome; neurosteroids; stress; visceral obesity

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIDEPRESSANT AGENT; CORTICOSTERONE; HYDROCORTISONE; PRASTERONE;

COGNITIVE DEFECT; CUSHING SYNDROME; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; METABOLISM; PSYCHOLOGICAL ASPECT; REVIEW;

ANTIDEPRESSIVE AGENTS; COGNITION DISORDERS; CORTICOSTERONE; CUSHING SYNDROME; DEHYDROEPIANDROSTERONE; DEPRESSIVE DISORDER, MAJOR; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROTRANSMITTER AGENTS; PITUITARY-ADRENAL SYSTEM;

EID: 0035413129     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970109026799     Document Type: Review

References (389)

1. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS (2000) Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20:2896-2903.
2. Amsterdam J, Mosley PD, Rosenzweig M (1994) Assessment of adrenocortical activity in refractory depression: steroid suppression with ketoconazole. In: Nolan W, Zohar J, Roose S, Amsterdam J (eds) Refractory Depression. John Wiley, Chichester, pp 199-210.
3. Anand A, Malison R, McDougle CJ, Price L. H (1995) Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report. Biol Psychiatry 37:338-340.
4. Angeli A, Frairia R (1985) Ketoconazole therapy in Cushing's disease [letter]. Lancet 1:821.
5. Arana GW (1991) Intravenous dexamethasone for symptoms of major depressive disorder [letter]. Am J Psychiatry 148:1401-1402.
6. Arana GW, Santos AB, Laraia MT, McLeod-Bryant S, Beale MD, Rames LJ, Roberts JM, Dias JK, Molloy M (1995) Dexamethasone for the treatment of depression: a randomized, placebo-controlled, double-blind trial. Am J Psychiatry 152:265-267.
7. Arlt W, Justl HG, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83:1928-1934.
8. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020.
9. Arnetz BB, Theorell T, Levi L, Kallner A, Eneroth P (1983) An experimental study of social isolation of elderly people: psychoendocrine and metabolic effects. Psychosomatic Med 45:395-406.
10. Arteaga E, Mahana D, Gonzalez R, Martinez P (1989) [Cushing syndrome caused by macronodular adrenal hyperplasia, independent of ACTH: report of a case]. Rev Med Chil 117:1398-1402.
11. Barbieri M, Rosaria Rizzo M, Manzella D, Paolisso G (2001) Agerelated insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev 17:19-26.
12. Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters and health-related quality of life. J Clin Endocrinol Metab 84:3896-3902.
13. Barrett-Connor E, Von Huhlen DC, Kritz-Silverstein D (1999) Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 84:573-577.
14. Barrot M, Vallee M, Cingras MA, Le Moal M, Mayo W, Piazza PV (1999) The neurosteroid pregnenolone sulfate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens. Eur J Neuroscience 11:3757-3760.
15. Bastianetto S, Ramassamy C, Poirier J, Quirion R (1999) Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35-41.
16. Baulieu EE (1997) Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52:1-32.
17. Baulieu E, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharriere O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 97:4279-4284.
18. Beale MD, Arana GW (1995) Dexamethasone for treatment of major depression in patients with bipolar disorder [letter]. Am J Psychiatry 152:959-960.
19. Bech P, Raabaek Olsen L, Jarlov N, Hammer M, Schutze T, Breum L (1999) A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors. Acta Psychiatrica Scand 100:76-78.
20. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F (1997) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101-106.
21. Belanoff J, Schatzberg AF (2000) Glucocorticoid antagonists. Neuropsychopharmacology 23: S56.
22. Berneis K, Keller U (1996) Metabolic actions of growth hormone: direct and indirect. Ballieres Clinical Endocrinology and Metabolism 10:337-353.
23. Berwaerts JJ, Verhelst JA, Verhaert GC, Verhaegen AA, Abs RE (1998) Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole. J Am Geriatr Soc 46:880-884.
24. Biegon A (1990) Effects of steroid hormones on the serotonergic system. Ann N Y Acad Sci 600:427-432.
25. Bittman BB, Berk LS, Felten DL, Westengard J, Simonton OC, Pappas J, Ninehouser M (2001) Composite effects of group drumming therapy on modulation of neuroendocrine-immune parameters in normal subjects. Altern Ther Health Med 7:38-47.
26. Bjorntorp P (1997) Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 9:795-803.
27. Bjorntorp P (In Press) Hypothalamic Origin of Prevalent Human Disease: In: Pfaff D, Arnold A, Etgen A, Fahrbach S, Rubin R,: Hormones, Brain and Behavior. San Diego: Academic Press.
28. Bjorntorp P, Holm G, Rosmond R (1999a) Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus. Diabet Med 16:373-383.
29. Bjorntorp P, Holm G, Rosmond R (1999b) Hypothalamic arousal, insulin resistance, and Type 2 diabetes mellitus. Diabetic Medicine 16:373-383.
30. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR (1999) Dehydroepiandrosterone treatment of mid-life dysthymia. Biol Psychiat 45:1533-1541.
31. Bodani M, Sheehan B, Philpot M (1999) The use of dexamethasone in elderly patients with antidepressant-resistant depressive illness. J Psychopharmacol 13:196-197.
32. Boston Collaborative Drug Surveillance Program (1972) Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694-698.
33. Boudou P, De Kerviler E, Vxiau P, Fiet J, Cathelineau G, Gautier J (2000) Effects of a single bout of exercise and exercise training on steroid levels in middle-aged type 2 diabetic men: relationship to abdominal adipose tissue distribution and metabolic status. Diabetes Metab 26:450-457.
34. Bouwer C, Claassen J, Dinan TG, Nemeroff CB (2000) Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolemia: a case series. Depress Anxiety 12:44-50.
35. Bray G (1985) Autonomic and endocrine factors in the regulation of food intake. Brain Research Bulletin 14:505-510.
36. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM (1988) Controllable and uncontrollable stress in humans: Alterations in mood and neuroendocrine and psychophysiological function. Am J Psychiatry 144:1419-1425.
37. Bremner JD (1999) Does stress damage the brain? Biol Psychiatry 45:797-805.
38. Brown ES, Bobadilla L, Rush AJ (2001) Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review. Bipolar Disord 3:23-29.
39. Browne ES, Wright BE, Porter JR, Svec F (1992) Dehydroepiandrosterone: antiglucocorticoid action in mice. Am) Med Sci 303:366-371.
40. Cameron HA, McKay RD (1999) Restoring production of hippocampal neurons in old age. Nat Neurosci 2:894-897.
41. Cameron OG, Addy RO, Malitz D (1985) Effects of ACTH and prednisone on mood: incidence and time of onset. Int J Psychiatry Med 15:213-223.
42. Cardounel A, Regelson W, Kalimi M (1999) Dehydroepiandrosterone protects hippocampal neurons against neurotoxininduced cell death: mechanism of action. Proc Soc Exp Biol Med 222:145-149.
43. Castillo-Richmond A, Schneider R, Alexander C, Cook R, Myers H, Nidich S, Haney C, Rainforth M, Salerno J (2000) Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 31:568-573.
44. Chauloff F (1993) Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Research Reviews 18:1-32.
45. Checkley AS, O'Dwyer AM, Raven P, Taylor N, Lightman S (1994) Antidepressant effects of treatments with metyrapone and hydrocortisone. Biol Psychiatry 35:711.
46. Chouinard G, Belanger MC, Beauclair L, Sultan S, Murphy BE (1996) Potentiation of fluoxetine by aminoglutethimide, an adrenal steroid suppressant, in obsessive-compulsive disorder resistant to SSRIs: a case report. Prog Neuropsychopharmacol Biol Psychiatry 20:1067-1079.
47. Christeff N, Nunez EA, Gougeon ML (2000) Changes in cortisol/DHEA ratio in HIV-infected men are related to immunological and metabolic perturbations leading to malnutrition and lipodystrophy. Ann NY Acad Sci 917:962-970.
48. Cleghorn RA (1951) Adrenal cortical insufficiency: psychological and neurologic observations. Canada MAJ 65:449-454.
49. Cohen SI (1980) Cushing's syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120-124.
50. Cohen Jl (2000) Stress and mental health. Issues Mental Health Nursing 21:185-202.
51. Coleman D, Leiter E, Schwizer R (1982) Therapeutic effects of dehydroepiandrosterone in diabetic mice. Diabetes 31:830-833.
52. Cruess DC, Antoni MH, Kumar M, Ironson G, McCabe P, Fernandez JB, Fletcher MA, Schneiderman N (1999) Cognitive-behavioral stress management buffers decreases in dehydroepiandrosterone sulfate (DHEA-S) and increases in the cortisol/DHEA-S ration and reduces mood disturbance and perceived stress among HIV-seropositive men. Psychoneuroendocrinology 24:537-549.
53. Cruess DG, Antoni MH, Kumar M, Schneiderman N (2000) Reductions in salivary Cortisol are associated with mood improvement during relaxation training among HIV-seropositive men. J Behav Med 23:107-122.
54. Curzon G (1994) Effects of stress on 5-HT function. Neuropsychopharmacoiogy 10:928S.
55. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.
56. de Leon MJ, McRae T, Rusinek H, Convit A, De Santi S, Tarshish C, Golomb J, Volkow N, Daisley K, Orentreich N, McEwen B (1997) Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab 82:3251-3259.
57. Deak F, Lasztoczi B, Pacher P, Petheo GL, Valeria K, Spat A (2000) Inhibition of voltage-gated calcium channels by fluoxetine in rat hippocampal pyramidal cells. Neuropharmacology 39:1029-1036.
58. DeBattista C, Posener JA, Kalehzan BM, Schatzberg AF (2000) Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: A double-blind, placebo-controlled study. Am J Psychiatry 157:1334-1337.
59. Deroche V, Marinelli M, Le Moal M, Piazza PV (1997) Glucocorticoids and behavioral effects of psychostimulants. II: Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281:1401-1407.
60. Diamond DM, Fleshner M (2000) Constraints on the DHEAS-induced enhancement of hippocampal function: non-linear doseresponse functions and DHEAS-stress interactions. In: Kalimi M, Regelson W (eds) Dehydroepiandrosterone (DHEA): Biochemical, Physiological and Clinical Aspects. Walter de Guyter, Berlin, pp 261-270.
61. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F (1996) Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150 Suppl: S43-50.
62. Dinan TG, Lavelle E, Cooney J, Burnett F, Scott L, Dash A, Thakore J, Berti C (1997) Dexamethasone augmentation in treatmentresistant depression. Acta Psychiatr Scand 95:58-61.
63. Dong-Ho H, Hansen P, Chen M, Hoiloszy J (1998) DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats. Journal of Gerontology 53: B19-B24.
64. Drugan RC, Basile AS, Ha JH, Ferland RJ (1994) The protective effects of stress control may be mediated by increased brain levels of benzodiazepine receptor agonists. Brain Res 661:127-136.
65. Dubrovsky B (1991) Adrenal steroids and the physiopathology of a subset of depressive disorders. Med Hypotheses 36:300-305.
66. Dubrovsky B (1997) Natural steroids counteracting some actions of putative depressogenic steroids on the central nervous system: potential therapeutic benefits. Med Hypotheses 49:51-55.
67. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
68. Elliott EM, Mattson MP, Vanderklish P, Lynch G, Chang I, Sapolsky RM (1993) Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J Neurochem 61:57-67.
69. Epel E, McEwen B, Ickovics J (1998) Embodying psychological thriving: Physical thriving in response to stress. Journal of Social Issues 54:301-322.
70. Epel E, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell K, Bell J, Ickovics J (2000a) Stress and body shape: Consistently greater stress-induced Cortisol reactivity among women with abdominal fat. Psychosomatic Medicine 62:623-632.
71. Epel E, Kiratli J, Young B, Chapman J, Hegde S, Standard S, Osterberg L (2001) Stress reduction for Type II Diabetics reduces visceral adiposity. Manuscript in progress.
72. Epel E, Lapidus R, Brownell K, McEwen B (2000b) Stress may add bite to appetite in women: A laboratory study of stress-induced Cortisol and eating behavior. Psychoneuroendocrinology 26:37-49.
73. Eriksen HR, Olff M, Murison R, Ursin H (1999) The time dimension in stress responses: Relevance for survival and health. Psychiatry res 85:39-50.
74. Ernest I, Ekman H (1972) Adrenalectomy in Cushing's disease. Acta Endocrinol 160:4-41.
75. Fahrion S, Norris P, Green E, Green A, Schnar R (1987) Biobehavioral treatment of essential hypertension. Biofeedback and Self-Regulation 11:257-278.
76. Falkenberg T, Mohammed AK, Henriksson B, Persson H, Winblad B, Lindefors N (1992) Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett 138:153-156.
77. Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, Fioravanti M, Cuzzoni G, Pontiggia B, Magri F (2001) Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur J Endocrinol 144:319-329.
78. Field T, Morrow C, Valdeon C, Larson S, Kuhn C, Schanberg S (1992) Massage reduces anxiety in child and adolescent psyschiatric patients. Child Adolescence 31:125-131.
79. Field T, Schanberg S, Kuhn C, Field T, Fierro K, Henteleff T, Mueller C, Yando R, Shaw S, Burman I (1998) Bulimic adolescents benefit from massage therapy. Adolescence 33:555-563.
80. Flugge G, Kramer M, Rensing S, Fuchs E (1998) 5HT1A-receptors and behavior under chronic stress: selective counteraction by testosterone. Eur J Neurosci 10:2685-2693.
81. Frank C, Sagratella S (2000) Neuroprotective effects of allopregnanolone on hippocampal irreversible neurotoxicity in vitro. Prog Neuropsychopharmacol Biol Psychiatry 24:1117-1126.
82. Friedlander AL, Butterfield GE, Moynihan S, Grillo J, Pollack M, Holloway L, Friedman L, Yesavage J, Matthias D, Lee S, Marcus R, Hoffman AR (2001) One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J C in Endocrinol Metab 86:1496-1503.
83. Gallois P, Forzy G, Dhont J (1984) [Hormonal changes during relaxation]. L'encephale 10:79-82.
84. George MS, Guidotti A, Rubinow D, Pan P, Mikalauskas K, Post RM (1994) CSF neuroactive steroids in affective disorders: pregnenolone, progesterone and DBI. Biol Psychiatry 35:775-780.
85. Geracioti TD, Jr., Orth DN, Ekhator NN, Blumenkop B, Loosen PT (1992) Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab 74:1325-1330.
86. Geringer E (1990) Affective Disorders and Diabetes Mellitus. In: Holmes C (ed), Neuropsychological and Behavioral Aspects of Diabetes. Springer-Verlag, New York, pp 239-272.
87. Ghadirian AM, Englesmann F, Dhar V, Filipini D, Kelle R, Chouinard G, Murphy BEP (1995) The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment. Biol Psychiatry 37:369-375.
88. Gifford S, Gunderson JG (1970) Cushing's Disease as a psychosomatic disorder: a selective review of the clinical and experimental literature and a report of ten cases. Perspectives Biol Med 13:169-221.
89. Claser JL, Brind JL, Vogelman JH, Eisner MJ, Dillbeck MC, Wallace RK, Chopra D, Orentreich N (1992) Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs. J Behav Med 15:327-341.
90. Goeders NE (1997) A neuroendocrine role in cocaine reinforcement. Psychoneuroendocrinology 22:237-259.
91. Cold PW, Chrousos GP (1985) Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency. Psychoneuroendocrinol 10:401-419.
92. Gold PW, Chrousos GP (1999) The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians 111:22-34.
93. Goodwin GM, Muir WJ, Seckl JR, Bennie J, Carroll S, Dick H, Fink G (1992) The effects of Cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls. J Affect Disord 26:73-83.
94. Goodyer IM, Herbert J, Altham PM, Pearson J, Secher SM, Shiers HM (1996) Adrenal secretion during major depression in 8-to 16-year-olds, I. Altered diurnal rhythms in salivary Cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol Med 26:245-256.
95. Goodyer IM, Herbert J, Altham PM (1998) Adrenal steroid secretion and major depression in 8-to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression. Psychol Med 28:265-273.
96. Gould E, Tanapat P (1999) Stress and hippocampal neurogenesis. Biol Psychiatry 46:1472-1479.
97. Gould E, Cameron HA, McEwen BS (1994) Blockade of NMDA receptors increases cell death and birth in the developing dentate gyrus. J Comp Neurol 340:551-565.
98. Gould E, Reeves AJ, Graziano MSA, Gross CG (1999) Neurogenesis in the neocortex of adult primates. Science 286:548-552.
99. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40:493-500.
100. Greeno C, Wing R (1994) Stress-induced eating. Psychological Bulletin 115:444-464.
101. Griffin LD, Mellon SH (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci 96:13512-13517.
102. Grundy PL, Patel N, Harbuz MS, Lightman SL, Sharpies PM (2000) Glucocorticoids modulate BDNF mRNA expression in the rat hippocampus after traumatic brain injury. Neuroreport 11:3381-3384.
103. Guo AL, Petraglia F, Criscuolo M, Ficarra G, Nappi RE, Palumbo MA, Trentini GP, Purdy RH, Genazzani AR (1995) Evidence for a role of neurosteroids in odulation of diurnal changes and acute stressinduced corticosterone secretion in rats. Gyn Endocrinol 9:1-7.
104. Gutman DA, Owens MJ, Skelton KH, Knight DL, Thrivirkraman KV, Plotsky PM, Nemeroff CB (2000) Behavioral, neuroendocrine, and pharmacokinetic observations on CRF-1-selective antagonist, R121919 in the rat. Neuropsychopharmacology 23: SI19.
105. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW (2000) Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 97:6079-6084.
106. Haleem DJ, Kennett C, Curzon G (1988) Adaptation of female rats to stress: Shift to male pattern by inhibition of corticosterone synthesis. Brain Res 458:339-347.
107. Hall RC, Popkin MK, Stickney SK, Gardner ER (1979) Presentation of the steroid psychoses. J Nerv Ment Dis 167:229-236.
108. Hamm FC (1955) Adrenal surgery for psychosis associated with Cushing's syndrome. Arch Surg 71:617-619.
109. Hardy JR, Rees E, Ling J, Burman R, Feuer D, Broadley K, Stone P (2001) A prospective study of the use of dexamethasone on a palliative care unit. Palliat Med 15:3-8.
110. Haskett RF (1985) Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 142:911-916.
111. Healy DG, Harkin A, Cryan JF, Kelly JP, Leonard BE (1999) Metyrapone displays antidpressant-like effects in preclinical paradigms. Psychopharmacology (Berl) 145:303-308.
112. Hechter O, Grossman A, Chatterton Jr, RT (1997) Relationship of dehydroepiandrosterone and Cortisol in disease. Med Hypotheses 49:85-91.
113. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M (1999) Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 89:97-106.
114. Herbert J (1997) Fortnightly review. Stress, the brain, and mental illness. BMJ 315:530-535.
115. Herbert J (1998) Neurosteroids, brain damage, and mental illness. Exp Gerontol 33:713-727.
116. Herbert J, Goodyer IM, Altham PME, Pearson J, Secher SM, Shiers HM (1996) Adrenal secretion and major depression in 8-to 16-year-olds, II. Influence of co-morbidity at presentation. Psychol Med 26:257-263.
117. Hirsch D, Orr G, Kantarovich V, Hermesh H, Stern E, Blum I (2000) Cushing's syndrome presenting as a schizophrenia-like psychotic state. Isr J Psychiatry Relat Sci 37:46-50.
118. Holsboer F (1988) Implications of altered limbic-hypothalamicpituitary- adrenocortical (LHPA)-function for neurobiology of depression. Acta Psychiatr Scand Suppl 341:72-111.
119. Holsboer F (1999) The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33:181-214.
120. Holsboer F (2000) Molecular approaches and the CRH hypothesis of mood and anxiety disorders, CRF Antagonists. Held during the 2nd International Congress on Hormones, Brain and Neuropsychopharmacology, Rhodes, Greece.
121. Holsboer F, Barden N (1996) Antidepressants and hypothalamicpituitary- adrenocortical regulation. Endocr Rev 17:187-205.
122. Howard III JS (1992) Severe psychosis and the adrenal androgens. Integr Physiol Behav Sci 27:209-215.
123. Hu Y, Cardounel A, Gursoy E, Anderson P, Kalimi M (2000) Antistress effects of dehydroepiandrosterone: protection of rats against repeated immobilixation stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation. Biochem Pharmacol 59:753-762.
124. Hudson J, Hudson M, Rothschild A, Vignati L, Schatzburg A, Melby J (1984) Abnormal results of dexamethasone suppression tests in nondepressed pteints with diabetes mellitus. Archives of General Psychiatry 41:1086-1089.
125. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650-4656.
126. Huppert FA, Van Niekerk JK (2001) Dehydroepiandrosterone (DHEA) supplementation for cognitive function (Cochrane Review), Cochrane Database Syst Rev, 2.
127. lizuka H, Kishimotor A, Nakamura J, Mizukawa R (1996) Clinical effects of Cortisol synthesis inhibition on treatment-resistant depression. Ninon Shinkei Seishin Yakurigaku Zasshi 16:33-36.
128. Jacobs BL, Tanapat P, Reeves AJ, Could E (1998) Serotonin stimulates the production of new hippocampal granule cells via the 5HT-1A receptor in the adult rat. Soc Neurosci Abstr 24:1992.
129. Jacobs AR, Edelheit PB, Coleman AE, Herzog AG (1999) Late-onset congenital adrenal hyperplasia: a treatable cause of anxiety. Biol Psychiatry 46:856-859.
130. Jacobs BL, van Praag H, Gage FH (2000) Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5:262-269.
131. Jayo JM, Shively CA, Kaplan JR, Manuck SB (1993) Effects of exercise and stress on body fat distribution in male cynomolgus monkeys. International Journal of Obesity and Related Metabolic Disorders 17:597-604.
132. Jeffcoate WJ, Silverstone JT, Edwards CR, Besser CM (1979) Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma Cortisol. Q J Med 48:465-472.
133. Jevning R, Wilson A, Davidson J (1978) Adrenocortical activity during meditation. Hormones and Behavior 10:54-60.
134. Joels M, Karten Y, Hesen W, de Kloet ER (1997) Corticosteroid effects on electrical properties of brain cells: temporal aspects and role of antiglucocorticoids. Psychoneuroendocrinology 22: S81-86.
135. Kagan B, Leskin G, Haas B, Wilkins J, Foy D (1999) Elevated lipid levels in Vietnam Veterans with Chronic Posttraumatic Stress Disorder. Biological Psychiatry 45:374-377.
136. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W (1994) Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 131:99-104.
137. Karst H, de Kloet ER, Joels M (1997) Effect of ORG 34116, a corticosteroid receptor antagonist, on hippocampal Ca2+ currents. Eur J Pharmacol 339:17-26.
138. Katz S, Morales AJ (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DS) as therapeutic options in menopause. Semin Reprod Endocrinol 16:161-170.
139. Kawakami N, Shimizu H, Takatsuka N, Ishibashi H (1999) Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 22:1071-1076.
140. Keenan PA, Jacobson MW, Soleymani RM, Newcomer JW (1995) Commonly used therapeutic doses of glucocorticoids impair explicit memory. Ann N Y Acad Sci 761:400-402.
141. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT (1996) The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47:1396-1402.
142. Kelly WF, Barnes AJ, Cassar J, White M, Mashiter K, Loizou S, Welbourn RB, Joplin GF (1979) Cushing's syndrome due to adrenocortical carcinoma-a comprehensive clinical and biochemical study of patients treated by surgery and chemotherapy. Acta Endocrinolologica 91:303-318.
143. Kelly WF, Checkley SA, Bender DA (1980) Cushing's syndrome, tryptophan and depression. Br J Psychiatry 136:125-132.
144. Kelly WF, Checkley SA, Bender DA, Mashiter K (1983) Cushing's syndrome and depression-a prospective study of 26 patients. Br J Psychiatry 142:16-19.
145. Kelly WF, Kelly MJ, Faragher B (1996) A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol 45:715-772.
146. Kempermann G, Kuhn HG, Gage FH (1997) More hippocampal neurons in adult mice living in an enriched environment. Nature 386:493-495.
147. Kennett GA, Dickinson SL, Curzon G (1985) Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone. Eur J Pharmacol 119:143-152.
148. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA 95:1852-1857.
149. Kimonides VG, Spillantini MG, Sofroniew MV, Fawcett JW, Herbert J (1999) Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 89:429-436.
150. Kirschbaum C, Wolf OT, May M (1996) Stress and treatment induced elevations of Cortisol levies associated with impaired declarative memory in healthy adults. Life Sciences 58:1475-1483.
151. Kissebah AH, Krakower G (1994) Regional adiposity and morbidity. Physiol Rev 74:761-811.
152. Kline MD, Jaggers ED (1999) Mania onset while using dehydroepiandrosterone. Am J Psychiatry 156:971.
153. Kling MA, Perini GI, Demitrack MA, Geracioti TD, Linnoila M, Chrousos GP, Gold PW (1989) Stress-responsive neurohormonal systems and the symptom complex of affective illness. Psychopharmacol Bull 25:312-318.
154. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ Jr, May C, Post RM, Chrousos GP, Gold PW (1991) Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab 72:260-271.
155. Koo E, Katalin FG, Tibor F, Gyorgy EF (1987) Experiences with dehydroepiandrosterone therapy in steroid-dependent intrinsic bronchial asthma. Orvosi-Hetilap 38:1995-1997.
156. Kramlinger KG, Peterson GC, Watson PK, Leonard LL (1985) Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics 26:67, 71.
157. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF (1999) DHEA and DHEA-S: a review. J Clin Pharmacol 39:327-348.
158. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498-3505.
159. Leblhuber F, Windhager E, Neubauer C, Weber J, Reisecker F, Dienstl E (1992) Antiglucocorticoid effects of DHEA-S in Alzheimer's disease [letter]. [published erratum appears in Am J Psychiatry 1992 Nov; 49(11):1622].
160. Am J Psychiatry 149:1125-1126.
161. Leigh H, Kramer SI (1984) The psychiatric manifestations of endocrine disease. Adv Intern Med 29:413-445.
162. Lesch KP, Lerer B (1991) The 5-HT receptor-G-protein-effector system complex in depression. I. Effect of glucocorticoids. J Neural Transm Gen Sect 84:3-18.
163. Leverenz JB, Wilkinson CW, Wamble M, Corbin S, Grabber JE, Raskind MA, Peskind ER (1999) Effect of high-dose exogenous Cortisol on hippocampal neuronal number in aged nonhuman primates. J Neurosci 19:2356-2361.
164. Levine A, Mitty H (1988) Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma. Journal of Urology 140:11-15.
165. Lewis DA, Smith RE (1983) Steroid induced psychiatric syndromes. J Affective Disord 5:319-332.
166. Li KL, Tung SC, Wang PW (1996) The effect of ketoconazole in pre-operative treatment in Cushing's syndrome: three cases report. Chang Keng I Hsueh 19:358-363.
167. Ling MH, Perry PJ, Tsuang MT (1981) Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry 38:471-477.
168. Littman AB, Fava M, Halperin P, Lamon-Fava S, Drews FR, Oleshansky MA, Bielenda CC, MacLaughlin RA (1993) Physiologic benefits of a stress reduction program for healthy middle-aged Army officers. J Psychosom Res 37:345-354.
169. Lobo A, Perez-Echeverria MJ, Jimenez-Aznarez A, Sancho MA (1988) Emotional disturbances in endocrine patients. Validity of the scaled version of the General Health Questionnaire (GHQ-28). Br J Psychiatry 152:807-812.
170. Lbkk J (1998) Psychoendocrine concomitants in patients following a new design of a geriatric day-care unit. Psychother Psychosom 67:323-327.
171. Loli P, Berselli ME, Tagliaferri M (1986) Use of ketoconazole in the treatment of Cushing's syndrome. J Clin Endocrinol Metab 63:1365-1371.
172. Loosen PT, Chambliss B, DeBold CR, Shelton R, Orth DN (1992) Psychiatric phenomenology in Cushing's disease. Pharmacopsychiatry 25:192-198.
173. Lopez JF, Chalmers DT, Little KY, Watson SJ (1998) Regulation of serotonin 1 A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547-573.
174. Lucassen PJ, Muller MB, Holsboer F, Bauer J, Holtrop A, Wouda J, Hoogendijk WJ, De Kloet ER, Swaab DF (2001) Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 158:453-468.
175. Lupien SJ, McEwen BS (1997) The acute effects of corticosteroids on cognition: integration of animal and human studies. Brain Res Rev 24:1-27.
176. Lupien SJ, Nair NP, Briere S, Maheu F, Tu MT, Lemay M, McEwen BS, Meaney MJ (1999) Increased Cortisol levels and impaired cognition in human aging:
177. Lustman P, Griffith L, Freedland K, Kissel S, Clouse R (1998) Cognitive behavior therapy for depression in type 2 diabetes: A randomized controlled trial. Annals of Internal Medicine 129:613-621.
178. Lynch CD, Lyons D, Khan A, Bennett SA, Sonntag WE (2001) Insulin-like growth factor-1 selectively increases glucose utilization in brains of aged animals. Endocrinology 142:506-509.
179. Maclean C, Walton K, Wenneberg S, Levitsky D, Mandarino J, Waziri R, Hillis S, Schneider R (1997) Effects of the Transcendental Meditation program on adaptive mechanisms: Changes in hormone levels and respones to stress after 4 months of practice. Psychoneuroendocrinology 22:277-295.
180. Maes M, Meltzer HY (1995) The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: The Fourth Generation of Progress. Raven Press Ltd, New York, pp 933-944.
181. Magri F, Terenzi F, Ricciardi T, Fioravanti M, Solerte SB, Stabile M, Balza G, Gandini C, Villa M, Ferrari E (2000) Association between changes in adrenal secretion and cerebral morphometric correlates in normal aging and senile dementia. Dement Geriatr Cogn Disord 11:90-99.
182. Majewska MD (1987) Steroids and brain activity. Essential dialogue between body and mind. Biochem Pharmacol 36:3781-3788.
183. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus, j Neurosci 20:9104-9110.
184. Malison RT, Anand A, Pelton GH, Kirwin P, Carpenter L, McDougle CJ, Heninger GR, Price LH (1999) Limited efficacy of ketoconazole in treatment-refractory major depression. J Clin Psychopharmacology 19:466-470.
185. Mancini A, Bianchi A, Milardi D, Gentilella R, Giampietro A, Vezzosi C, Perrelli M, De Marinis L (1999) Cushing's syndrome: psychiatric involvement as important aspect of the clinical picture in old age. J Endocrinol Invest 22:83-84.
186. Mangat HS, Islam A, Heigenskold C, Mustafa A, Winblad B, Adem A (1998) Long-term adrenalectomy decreases NMDA receptors in rat hippocampus. Neuroreport 9:2011-2014.
187. Manji HK, Moore GJ, Rajkowska G, Chen G (2000) Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5:578-593.
188. Mao X, Barger SW (1998) Neuroprotection by dehydroepiandrosterone- sulfate: role of an NFkappaB-like factor. Neuroreport 9:759-763.
189. Marco E, Wolkowitz OM, Vinogradov SP, J., Lichtmacher J, Reus VI (In Review) Double-blind anti-glucocorticoid treatment of schizophrenia and schizoaffective disorder.
190. Margolese HC (2000) The male menopause and mood: testosterone decline and depression in the aging male-is there a link? J Geriatr Psychiatry Neurol 13:93-101.
191. Marin P (1995) Testosterone and regional fat distribution. Obesity Research 3:609s-612s.
192. Markowitz JS, Carson WH, Jackson CW (1999) Possible dehydroepiandrosterone-induced mania. Biol Psychiat 45:241-242.
193. Martignoni E, Costa A, Sinforiani E, Luizzi P, Chiodini M, Mauri M, Bono G, Nappi G (1992) The brain as a target for adrenocortical steroids: Cognitive implications. Psychoneuroendocrinology 17:343-354.
194. Matoulek M, Hampl R, Svacina S, Sulcova J, Haas T (2000) [No title available]. Cas Lek Cesk 139:772-775.
195. Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nappi G (1993) Memory impairment in Cushing's disease. Acta Neurol Scand 87:52-55.
196. Maurice T, Phan VL, Urani A, Kamei H, Noda Y, Nabeshima T (1999) Neuroactive neurosteroids as endogenous effectors for the sigmal receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 81:125-155.
197. McCraty R, Barrios-Choplin B, Rozman D, Atkinson M, Watkins AD (1998) The impact of a new emotional self-management program on stress, emotions, heart rate variability, DHEA and Cortisol. Integr Physiol Behav Sci 33:151-170.
198. McEwen B (1968) Glucocoricoid-biogenic amine interactions in relation to mood and behavior. Biochemical Pharmacology 36:1755-1763.
199. McEwen BS (1987) Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol 36:1755-1763.
200. McEwen B (1998) Protective and damaging effects of stress mediators. New England Journal of Medicine 338:171-179.
201. McEwen B (2000a) Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology 22:108-124.
202. McEwen BS (2000b) Effects of adverse experiences for brain structure and function. Biol Psychiatry 48:721-731.
203. McEwen BS (2000c) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886:172-189.
204. McEwen BS, Magarinos AM (2001) Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Human Psychopharmacol Clin Exp 16: S7-S19.
205. McEwen B, Seeman T (1999) Protective and damaging effects of mediators of stress: Elaborating and testing the concepts of allostasis and allostatic load. Annals of the New York Academy of Sciences 896:30-47.
206. McEwen B, Stellar E (1993) Stress and the individual: Mechanisms leading to disease. Archives of Internal Medicine 153:2093-2191.
207. McEwen BS, Davis PC, Parsons B, Pfaff DW (1979) The brain as target for steroid hormone action. Annual Review of Neuroscience 2:65-112.
208. McEwen BS, Angulo J, Cameron H, Chao HM, Daniels D, Gannon MN, Gould E, Mendelson S, Sakai R, Spencer R (1992) Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol Psychiatry 31:177-199.
209. McGrady A, Horner J (1999) Role of mood in outcome of biofeedback assisted relaxation therapy in insulin dependent diabetes mellitus. Applied Psychophysiology 24:79-88.
210. McGrady A, Woerner M, Guillermo A, Bernal A, Higgins J (1987) Effect of biofeedback-assisted relaxation on blood pressure and Cortisol levels in normotensives and hypertensives, journal of Behavioral Medicine 10:301-310.
211. Meaney M, Aitken D, Bhatnagar S, Van Berkel C, Sapolsky R (1988) Postnatal handling attenuates neuroendocrine, anatomical, and cognitive impairments related to the aged hippocampus. Science 238:766-768.
212. Meieran S, Wolkowitz OM, Webster R, Shafton R, Reus VI (In Review) The effect of pregnenolone on mood, memory and arousal in normal and benzodiazepine-treated volunteers.
213. Meijer OC, Van Oosten RV, DeKloet ER (1997) Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine-1A receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience 80:419-426.
214. Michael-Titus AT, Bains S, jeetle J, Whelpton R (2000) Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex-a possible mechanism of neuroprotection in major depression? Neuroscience 100:681-684.
215. Michaels R, Parra J, McCann D, Vander J (1979) Renin, Cortisol, and aldosterone during transcendental meditation. Psychosomatic Medicine 41:50-54.
216. Mockel M, Rocker L, Stork T, Vollert J, Danne O, Eichstadt H, Muller R, Hochrein H (1994) Immediate physiological responses of healthy volunteers to different types of music: cardiovascular, hormonal and mental changes. [published erratum appears in Eur J Appl Physiol 1994;69(3):274]
217. Eur J Appl Physiol 68:451-459.
218. Mohammed AH, Henriksson BC, Soderstrom S, Ebendal T, Olsson T, Seckl JR (1993) Environmental influences on the central nervous system and their implications for the aging rat. Behav Brain Res 57:183-191.
219. Morales AJ, Nolan JJ, Nelson JC, Yen SS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. [published erratum appears in J Clin Endocrinol Metab 1995 Sep; 80(9):2799].
220. J Clin Endocrinol Metab 78:1360-1367.
221. Morales A, Haubricht R, Hwang J, Asakura H, Yen S (1998) The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone on circulating sex steroids, body composition and muscle strength in age advanced men and women. Clinical Endocrinology 49:421-432.
222. Morley JE, Kaiser F, Raum WJ, Perry HM 3rd, Flood JF, Jensen J, Silver AJ, Roberts E (1997) Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 94:7537-7542.
223. Moxley RT, 3rd (1994) Potential for growth factor treatment of muscle disease. Curr Opin Neurol 7:427-434.
224. Murialdo G, Nobili F, Rollero A, Gianelli MV, Copello F, Rodriguez G, Polleri A (2000) Hippocampal perfusion and pituitary-adrenal axis in Alzheimer's disease. Neuropsychobiology 42:51-57.
225. Murphy BE (1991a) Steroids and depression. J Steroid Biochem Mol Biol 38:537-559.
226. Murphy BE (1991b) Treatment of major depression with steroid suppressive drugs. J Steroid Biochem Mol Biol 39:239-244.
227. Murphy BEP (1997) Antiglucocorticoid therapies in major depression: A review. Psychoneuroendocrinology 22: S215-S132.
228. Murphy BEP, Wolkowitz OM (1993) The pathophysiologic significance of hypercorticism: antiglucocorticoid strategies. Psychiat Ann 23:682-690.
229. Murphy BE, Dhar V, Ghadirian AM, Chouinard G, Keller R (1991) Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 11:121-126.
230. Murphy BE, Filipini D, Ghadirian AM (1993) Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486. J Psychiatry Neurosci 18:209-213.
231. Murphy BE, Ghadirian AM, Dhar V (1998) Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy. Canadian Journal of Psychiatry 43:279-286.
232. Naber D, Sand P, Heigl B (1996) Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21:25-31.
233. Nair SM, Werkman TR, Craig J, Finnell R, Joels M, Eberwine JH (1998) Corticosteroid regulation of ion channel conductances and mRNA levels in individual hippocampal CA1 neurons. J Neurosci 18:2685-2696.
234. Nemeroff CB (1988) The role of corticotropin-releasirg factor in the pathogenesis of major depression. Pharmacopsychial 21:76-82.
235. Nemeroff CB (2000) Clinical studies on the role of CRF in mood and anxiety disorders, CRF Antagonists, Held during the 2nd International Congress on Hormones, Brain and Neuropsychopharmacology, Rhodes, Greece.
236. Nestler JE, Barlascini CO, Clore JN, Blackard WG (1988) Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 66:57-61.
237. Neto L, Fihlo A, Bustorff-Silva J, Koler H, Epelman S, Marini S, Junior G (2000) Pre-operative control of arterial hypertension using ketoconazole in pediatric patients with adrenocortical tumors. Journal of Pediatric Endocrinology and Metabolism 13:201-204.
238. Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL (1999) Decreased memory performance in healthy humans induced by stress-level Cortisol treatment. Arch Gen Psychiatry 56:527-533.
239. Newell-Price J, Jorgensen JO, Grossman A (1999) The diagnosis and differential diagnosis of Cushing's syndrome. Horm Res 51:81-94.
240. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
241. Nieman LK, Chrousos GP, Keliner C, Spitz IM, Nisula BC, Cutler GB, Merriam GR, Bardin CW, Loriaux DL (1985) Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 61:536-540.
242. Nilsson PM, Klasson EB, Nyberg P (2001) Life-style intervention at the worksite-reduction of cardiovascular risk factors in a randomized study. Scand J Work Environ Health 27:57-62.
243. Nyberg F (2000) Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 21:330-348.
244. O'Brien JT, Ames D, Schweitzer I, Colman P, Desmond P, Tress B (1996) Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary- adrenal axis function in depression and Alzheimer's disease. Br j Psychiatry 168:679-87.
245. O'Brien D, Skelton KH, Owens MJ, Nemeroff CB (2001) Are CRF recptor antagonists potential antidepressants? Hum Psychopharmacol Clin Exp 16:81-87.
246. O'Dwyer AM, Lightman SL, Marks MN, Checkley SA (1995) Treatment of major depression with metyrapone and hydrocortisone. Journal of Affective Disorders 33:123-128.
247. Ohl F, Michaels T, Vollmann-Honsdorf GK, Kirschbaum C, Fuchs E (2000) Effect of chronic psychosocial stress and long-term Cortisol treatment on hippocampus-mediated memory and hippocampal volume: a pilot study in tree shrews. Psychoneuroendocrinology 25:357-363.
248. Owens MJ, Nemeroff CB (1999) Corticotropin-releasing factor antagonists in affective disorders. Expert Opin Invest Drugs 8:1849-1858.
249. Pasquali R, Anconetani B, Chattat R, Biscotti M, Spinucci C, Casimirri F, Vicennati V, Carcello A, Labate A (1996) Hypothalamicpituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: Effects of the Corticotropin Releasing Factor/Arginine-Vasopressin test and of stress. Metabolism 45:351-356.
250. Patchev VK, Almeida OFX (1997) Daily DHEA or melatonin treatment prevents glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis, 2nd International Conference on Cortisol and Anti-cortisols, pp 46.
251. Patchev VK, Montkowski A, Rouskova D, Koranyi L, Hlsboer F, Almeida OFX (1997) Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest 99:962-966.
252. Pepin MC, Beaulieu S, Barden N (1990) Differential regulation by dexamethasone of glucocorticoid receptor messenger RNA concentrations in neuronal cultures derived from fetal rat hypothalamus and cerebral cortex. Cell Mol Neurobiol 10:227-235.
253. Perna FM, Antoni MH, Kumar M, Cruess DC, Schneiderman N (1998) Cognitive-behavioral intervention effects on mood and Cortisol during exercise training. Ann Behav Med 20:92-98.
254. Piazza PV, Le Moal ML (1996) Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36:359-378.
255. Pies R (1995) Differential diagnosis and treatment of steroidinduced affective syndromes. Gen Hosp Psychiatry 17:353-361.
256. Plihal W, Krug R, Pietrowsky R, Fehm HL, Born J (1996) Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 21:515-523.
257. Price LH, Cappiello A, Malison RT, McDougle CJ, Pelton GH, Schollnhammer G, Heninger GR (1997) Effects of antiglucocorticoid treatment on 5-HT1A function in depressed patients and healthy subjects. Neuropsycopharmacology 17:246-257.
258. Quarton GC, Clark LD, Cobb S, Bauer W (1955) Mental disturbances associated with ACTH and cortisone: A review of explanatory hypotheses. Medicine 34:13-50.
259. Raber J (1998) Detrimental effects of chronic hypothalamicpituitary- adrenal activation: From obesity to memory deficits. Mol Neurobiol 18:1-22.
260. Rabkin JG, Wagner GJ, Rabkin R (2000) A double-blind, placebocontrolled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Arch Gen Psychiatry 57:141-147.
261. Raikkonen K, Matthews K, Kuller L (2001). Psychosocial risk and the metabolic syndrome: prospective evidence from the healthy women study - submitted.
262. Raikkonen K, Matthews K, Kuller L, Reiber C, Bunker C (1999). Anger, hostility, and visceral adipose tissue in healthy postmenopausal women. Metabolism, 48, 1146-1151.
263. Rajkowska G (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766-777.
264. Rasika S, Alvarez-Buylla A, Nottebohm F (1999) BDNF mediates the effects of testosterone on the survival of new neurons in an adult brain. Neuron 22:53-62.
265. Ravaris CL, Sateia MJ, Beroza KW, Noordsy DL, Brinck-Johnsen T (1988) Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman [letter]. Arch Gen Psychiatry 45:966-967.
266. Ravaris CL, Brinck-Johnsen T, Elliott B (1994) Clinical use of ketoconazole in hypercortisoluric depressives. Biol Psychiatry 35:679.
267. Raven PW, O'Dwyer AM, Taylor NF, Checkley SA (1996) The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles. Psychoneuroendocrinol 21:277-286.
268. Rebuffe-Scrive M, Walsh U, McEwen B, Rodin J (1992) Effect of chronic stress and exogenous glucocorticoids on regional fat distribution and metabolism. Physiology and Behavior 52:583-590.
269. Reckart MD, Eisendrath SJ (1990) Exogenous corticosteroid effects on mood and cognition. Int J Psychosom 37:57-61.
270. Regestein QR, Rose LI, Williams GH (1972) Psychopathology in Cushing's sundrome. Arch Intern Med 130:114-117.
271. Reincke M (2000) Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 29:43-56.
272. Reus VI (1982) Pituitary-adrenal disinhibition as the independent variable in the assessment of behavioral symptoms. Biological Psychiatry 17:317-325.
273. Reus VI, Wolkowitz OM (1993) Behavioral side effects of corticosteroid therapy. Psychiatric Annals 23:703-708
274. Reus VI, Wolkowitz OM, Frederick S (1997) Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology 22: S121 - S124.
275. Ribeiro SC, Tandon R, Grunhaus L, Greden JF (1993) The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150:1618-1629.
276. Riedel M, Wiese A, Schurmeyer TH, Brabant G (1993) Qulaity of life in patients with Addison's disease: effects of different Cortisol replacement modes. Exp Clin Endocrinol 101:106-111.
277. Rizza R, Mandarino L, Gerich J (1982) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. Journal of Clinical Endocrinology and Metabolism 54:131-138.
278. Robinzon B, Cutolo M (1999) Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids? Rheumatology 38:488-495.
279. Romeo E, Strohle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910-913.
280. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ (2000) Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 39:1096-1103.
281. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G (2000) Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 85:1440-1448.
282. Rupprecht R (1997) The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 31:297-314.
283. Rupprecht R, Holsboer F (1999a) Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 22:410-416.
284. Rupprecht R, Holsboer F (1999b) Neuropsychopharmacological properties of neuroactive steroids. Steroids 64:83-91.
285. Rupprecht R, Strohle A, Hermann B, di Michele F, Spalletta C, Pasini A, Holsboer F, Romeo E (1998) Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunters. Biol Psychiatry 44:912-914.
286. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP (2001) Physical activity-antidepressant treatment combination: impact on brainderived neurotrophic factor and behavior in an animal model. Behav Brain Res 120:87-95.
287. Ryu H, Lee HS, Shin YS, Chung SM, Lee MS, Kim HM, Chung HT (1996) Acute effect of qigong training on stress hormonal levels in man. Am J Chin Med 24:193-198.
288. Saad MF, Adams F, Mackay B, Ordonez NG, Leavens ME, Samaan NA (1984) Occult Cushing's diseasepresenting with acute psychosis. Am J Med 76:759-766.
289. Sapolsky R, Romero M, Munck A (2000) How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 21:55-89.
290. Sapolsky RM (1993) Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav Brain Res 57:175-182.
291. Sapolsky RM (1994) The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann NY Acad Sci 746:294-307.
292. Sapolsky RM (1996) Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1:1-19.
293. Sapolsky RM (2000a) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-935.
294. Sapolsky RM (2000b) The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755-765.
295. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 7:284-301.
296. Sapolsky R, Uno H, Rebert C, Finch C (1990) Hippocampal Damage Asociated with Prolonged Gluccocorticoid Exposure in Primates. The lournal of Neuroscience 10:2897-2902.
297. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO (1985) A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 19:57-64.
298. Schulkin J, McEwen BS, Gold PW (1994) Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev 18:385-396.
299. Seeman T, Singer B, Rowe J, Horwitz R, McEwen B (1997) Price of adaptation-Allostatic load and its health consequences. Archives of Internal Medicine 157:2259-2268.
300. Seeman TE, McEwen BS, Rowe JW, Singer BH (2001) Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA 98:4770-4775.
301. Seidman SN, Walsh BT (1999) Testosterone and depression in aging men. Am J Geriatr Psychiatry 7:18-33.
302. Selye H (1956) The Stress of Life. McGraw-Hill, New York, NY.
303. Serra M, Pisu MG, Littera M, Papi G, Sanna E, Tuveri F, Usala L, Purdy RH, Biggio G (2000) Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA (A) receptor function in rat brain, J Neurochem 75:732-740.
304. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM (1998) Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 172:527-532.
305. Sheline Yl, Sanghavi M, Mintun MA, Gado MH (1999) Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19:5034-5043.
306. Singh VB, Kalimi M, Phan TH, Boadle-Biber MC (1994) Intracranial dehydroepiandrosterone blocks the activation of tryptophan hydroxylase in response to acute sound stress. Mol Cell Neurosci 5:176-181.
307. Sinha R, Catapano D, O'Malley S (1999) Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology (Berl) 142:343-351.
308. Sinha R, Fuse T, Aubin LR, O'Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharrracology (Berl) 152:140-148.
309. Slotkin TA, McCook EC, Ritchie JC, Seidler FJ (1996) Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol Psychiatry 40:576-584.
310. Smith MA, Makino S, Kvetnansky R, Post RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in hippocampus. J Neurosci 15:1768-1777.
311. Sonino N, Boscaro M, Ambroso G, Merola G, Mantero G (1986) Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide. IRCS Medical Science 14:485-486.
312. Sonino N, Boscaro M, Paoletta A, Mantero F, Ziliotto D (1991) Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol (Oxf) 35:347-352.
313. Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M (1993) Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease. Horm Res 39:202-206.
314. Souza N, Lukoyanov NV, Madeira MD, Almeida OFX, Paula-Barbosa MM (2000) Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97:253-266.
315. Sovner R, Fogelman S (1996) Ketoconazole therapy for atypical depression. J Clin Psychiatry 57:227-228.
316. Starkman MN (1987) Commentary on Majewska M: Actions of steroids on neurons: role in personality, mood, stress and disease. Integrative Psychiatry 5:258-273.
317. Starkman MN, Schteingart DE, Schork MA (1981) Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosom Med 43:3-18.
318. Starkman MN, Schteingart DE, Schork MA (1986) Cushing's syndrome after treatment: changes in Cortisol and ACTH levels, and amelioration of the depressive syndrome. Psyoiatry Res 19:177-188.
319. Starkman M, Gebarski S, Berent S, Schteingart D (1992) Hippocampal formation volume, memory dysfunction, and Cortisol levels in patients with Cushing's syndrome. Biological Psychiatry 32:756-765.
320. Starkman MN, Giordani B, Gebarski SS, Berent S, Schork MA, Schteingart DE (1999) Decrease in Cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry 46:1595-1602.
321. Sterling P, Eyer J (1988) Allostasis: A new paradigm to explain arousal pathology. In: Fisher S, Reason J (eds) Handbook of Life Stress: Cognition and Health. John Wiley & Sons Ltd, Chichester, pp 629-652.
322. Stewart J (2000) Pathways to relapse: the neurobiology of drugand stress-induced relapse to drug-taking. J Psychiatrv Neurosci 25:125-136.
323. Straub RH, Scholmerich J, Zietz B (2000) Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases-substitutes of adrenal and sex hormones. Z Rheumatol 59:11/108-118.
324. Sudsuang R, Chentazez V, Veluvan K (1991) Effect of Buddhist meditation on serum Cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiology and Behavior 50:543-548.
325. Surwit R, Williams P (1996) Animal models provide insight into psychosomatic factors in diabetes. Psychosomatic Medicine 58:582-589.
326. Svec F, Porter JR (1998) The actions of exogenous dehydroepiandrosterone in experimental animals and humans. P. S. E. B. M. 218:174-191.
327. Taft P, Martin FIR, Melick R (1970) Cushing's syndrome-a review of the response to treatment of 42 patients. Australian Ann Med 4:295-303.
328. Takebayashi M, Kagaya A, Inagaki M, Kozuru T, Jitsuiki H, Kurata K, Okamoto Y, Yamawaki S (2000) Effects of antidepressants on gamma-aminobutyric acid-and N-methyl-D-aspartate-induced intracellular Ca (2+) concentration increases in primary cultured rat cortical neurons. Neuropsychobiology 42:120-126.
329. Tannenbaum B, Brindley D, Tannenbaum G, Dallman J, McArthur D, Meaney M (1997) High-fat feeding alters both basal and stressinduced hypothalamic- pituitary-adrenal activity in the rat. American Journal of Physiology 273: E1168-1177.
330. Tataranni PA, Larson D, Snitker S, Young J, Flatt J, Ravussin E (1996) Effects of glucocorticoid on energy metabolism and food intake in humans. American Journal of Physiology 271: E317-325.
331. Thakore JH, Dinan T (1995) Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression. Biol Psychiatry 37:364-368.
332. Thakore J, Richards P, Reznek R, Martin A, Dinana T (1997) Increased intraabdominal fat in major depression. Biol Psychiatry 41:1140-1142.
333. Thase ME (1994) Cognitive-behavioral therapy of severe unipolar depression. In Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds), Refractory Depression: Current Strategies and Future Directions. John Wiley & Sons, Chichester, pp 269-296.
334. Thase M, Simons A, Reynolds C (1993) Psychobiological correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy. Psychopharmacology Bulletin 29:293-301.
335. Thompson JL, Butterfield GE, Gylfadottir UK, Yesavage J, Marcus R, Hintz RL, Pearman A, Hoffman AR (1998) Effects of human growth hormone, insulin-like growth factor l, and diet and exercise on body composition of obese postmenopausal women. J Clin Endocrinol Metab 83:1477-1484.
336. Tollefson CD, Haus E, Garvey MJ, Evans M, Tuason VB (1990) 24 hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmacotherapy. Ann Clin Psychiatry 2:39-45.
337. Trejo JL, Carro E, Torres-Aleman I (2001) Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21:1628-1634.
338. Trethowen WH, Cobb W (1952) Neuropsychiatric aspects of Cushing's syndrome. Arch Neurol Psychiat 67:283-309.
339. Uno H, Tarara R, Else J, Suleman M, Sapolsky R (1989) Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 9:1705-1711.
340. Urbanoski K, Harris J, Gijsbers K, Dubrovsky B (2000) Androsterone sulfate increases dentate gyrus population spike amplitude following tetanic stimulation. Physiol Behav 71:435-440.
341. Uzunov DP, Cooper TB, Costa E, Guidotti A (1996) Fluoxetineelicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA 93:12599-12604.
342. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95:3239-3244.
343. van der Lely AJ, Foeken K, van der Mast RC, Lamberts SW (1991) Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Intern Med 114:143-144.
344. van Vollenhoven RF (1997) Dehydroepiandrosterone: Uses and abuses. In: Kelley WN, Harris Jr ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology, Vol Update Series #25. W. B. Saunders Co., Philadelphia, PA, pp 1-25.
345. Van Vollenhoven RF, Engleman EG, McGuire JL (1994) An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis & Rheumatism 37:1305-1310.
346. Varney NR, Alexander B, Maclndoe JH (1984) Reversible steroid dementia in patients without steroid psychosis. Am. J Psychiatry 141:369-372.
347. Venero C, Borrell J (1999) Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur J Neurosci 11:2465-2473.
348. Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, Wass JA, Besser GM (1991) Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol (Oxf) 35:169-178.
349. Virgin Jr CE, Ha TP, Packan DR, Tombaugh CC, Yang SH, Horner HC, Sapolsky RM (1991) Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem 57:1422-1428.
350. Voigt KH, Bossert S, Bretschneider S, Bliestle A, Fehm HL (1985) Disturbed Cortisol secretion in man: contrasting Cushing's syndrome and endogenous depression. Psychiatry Res 15:341-350.
351. Walton G, Pugh N (1995) Stress, steroids, and "ojas": Neuroendocrine mechanisms and current promise of ancient approaches to disease prevention. Indian Journal of Physiology and Pharmacology 39:3-34.
352. Walton KG, Pugh ND, Gelderloos P, Macrae P (1995) Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. J Altern Complement Med 1:263-283.
353. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS (1996) Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab 81:3578-3583.
354. Weiss JM (1972) Psychological factors in stress and disease. Scientific American 226:104-113.
355. Welbourn RB, Montgomery DAD, Kennedy TL (1971) The natural history of treated Cushing's syndrome. Br J Surgery 58:1-16.
356. Wellman M, Shane-McWhorter L, Orlando X, Jennings JP (1999) The role of dehysroepiandrosterone in dibetes mellitus. Pharmacotherapy 19:582-591.
357. Whelan TB, Schteingart DE, Starkman MN, Smith A (1980) Neuropsychological deficits in Cushing's syndrome. J Nerv Ment Dis 168:753-757.
358. Whitehouse W, Dinges D, Orne E, Keller S, Bates B, Bauer N, Morahan P, Haupt B, Carlin M, Bloom P, Zaugg L, Orne M (1996) Psychosocial and immune effects of self-hypnosis training for stress management throughout the first
359. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendorfer RA, Pirke KM, Kirschbaum C (1997) Effects of a twoweek physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. Journal of Clinical Endocrinology and Metabolism 82:2363-2367.
360. Wolkowitz OM (1994) Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19:233-255.
361. Wolkowitz OM, Reus VI (1999) Treatment of depression with antiglucocorticoid drugs. Psychosomatic Medicine 61:698-711.
362. Wolkowitz OM, Reus VI (2000) Neuropsychiatry effects of Dehydroepiandrosterone (DHEA). In Kalimi M, Regelson W (eds) Dehydroepiandrosterone (DHEA): biochemical, physiological and clinical aspects. Walter de Gruyter, Berlin, pp 271-298.
363. Wolkowitz O, Sutton M, Koulu M (1986) Chronic corticosterone administration in rats: behavioral and biochemical evidence of increases in central dopaminergic activity. European Journal of Pharmacology 122:329-338.
364. Wolkowitz OM, Doran AR, Breier A, Roy A, Jimerson DC, Sutton ME, Golden RN, Paul SM, Pickar D (1987a) The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroidcatecholamine interactions in major depression. Arch Gen Psychiatry 44:782-789.
365. Wolkowitz OM, Rubinow DR, Breier A, Doran AR, Davis C, Pickar D (1987b) Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness. Life Sci 41:1929-1933.
366. Wolkowitz OM, Doran A, Breier A, Roy A, Pickar D (1989) Specificity of plasma HVA response to dexamethasone in psychotic depression. Psychiatry Res 29:177-86.
367. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D (1990a) Cognitive effects of corticosteroids. Am J Psychiatry 147:1297-1303.
368. Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, Pickar D (1990b) Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch Gen Psychiatry 47:963-968.
369. Wolkowitz OM, Reus VI, Manfredi F, Roberts E (1992) Antiglucocorticoid effects of DHEA-S in Alzheimer's Disease (Reply). Am J Psychiatry 149:1126.
370. Wolkowitz OM, Coppola R, Breier A, Doran AR, Rubinow DR, Berrettini WH, Kling MA, Pickar D (1993a) Quantitative electroencephalographic correlates of steroid administration in man. Neuropsychobiology 27:224-230.
371. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H (1993b) Ketoconazole treatment of hypercortisolemic depression. Am J Psychiatry 150:810-812.
372. Wolkowitz OM, Weingartner H, Rubinow DR, Jimerson D, Kling M, Berretini W, Thompson K, Breier A, Doran A, Reus VI, et al (1993c) Steroid modulation of human memory: biochemical correlates. Biol Psychiatry 33:744-746.
373. Wolkowitz OM, Reus VI, Manfred IF, Chan T, Canick J, Ormiston S, Ingbar J, Brizendine L (1994) Antiglucocorticoid medication effects on specific depressive symptoms. Biol Psychiatry 35:678.
374. Wolkowitz O, Reus V, Robers E, Manfredi F, Chan T (1995) Antidepressant and cognition-enhancing effects of DHEA in major depression. Annals of the New York Academy of Science 774:337-339.
375. Wolkowitz OM, Reus VI, Manfredi F, Chan T, Ormiston S, Johnson R (1996) Dexamethasone for depression [letter]. Am J Psychiatry 153:1112.
376. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997a) Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci 823:81-96.
377. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H (1997b) Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 41:311-318.
378. Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J (1999a) Antiglucocorticoid treatment of depression: Double-blind ketoconazole. Biol Psychiat 45:1070-1074.
379. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E (1999b) Double-blind treatment of major depression with dehydroepiandrosterone (DHEA). Am J Psychiatry 156:646-649.
380. Wolkowitz OM, Brizendine L, Reus VI (2000a) The Role of Dehydroepiandrosterone (DHEA) in Psychiatry. Psychiatric Annals 30:123-128.
381. Wolkowitz OM, Kramer J, Reus VI, Costa M, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, et al (2000b) DHEA treatment of Alzheimer's Disease: a randomized, double-blind, placebo-controlled study, The 2nd International Congress on Hormones, Brain and Neuropsychopharmacology, Rhodes, Greece.
382. Wolkowitz OM, Kroboth P, Reus VI, Fabian TJ (2000c) DHEA in Aging and Mental Health. In: Morrison M (ed) Hormones, Aging and Mental Disorders. Cambridge Univ Press, Cambridge, pp 144-167
383. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Ceracioti TD Jr. DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW (2000) Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97:325-330.
384. Xu L, Holscher C, Anwyl R, Rowan MJ (1998) Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress. Proc Natl Acad Sci USA 95:3204-3208.
385. Zahorodna A, Bijak M (1999) An antidepressant-induced decrease in the responsiveness of hippocampal neurons to group I matabotropic glutamate receptor activation. Eur J Pharmacol 386:173-179.
386. Zakon HH (1998) The effects of steroid hormones on electrical activity of excitable cells. Trends Neurosci 21:202-207.
387. Zeiger MA, Fraker DL, Pass HI, Nieman LK, Cutler GB Jr, Chrousos GP, Norton JA (1993) Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery 114:1138-1143.
388. Zobel AW, Yassouridid A, Frieboes RM, Holsboer F (1999) Prediction of medium-term outcome by Cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry 156:949-951.
389. Zobel AW, Nickel T, Kunzel HE, et al (2000) Effects of the highaffinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34:171-181.